Aprea Therapeutics has dosed a subject with human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) in Cohort 5 of the Phase I ACESOT-1051 trial evaluating APR-1051. In this ...

Cash, cash equivalents and marketable securities as of December 31, 2024 totaled $27.6M, compared to $48.5M for the year ended December 31, ...

Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today reported financial ...

Trial achieved key objectives for safety, tolerability, pharmacokinetics and pharmacodynamicsClinical data from this trial, together with ...

Drug development company Nyrada (ASX:NYR) has dosed the first cohort of patients in a trial to assess its lead drug candidate ...

PD-32766 for patients with clear cell renal cell carcinoma (ccRCC) was conducted at the National Cancer Center Hospital East and promising results were obtained. PET positive rate: 64 Cu-PD-32766 was ...

Pharmacokinetics studies how a drug is absorbed into the body over time — how it gets distributed through the blood and to ...

Melatonin acts on circadian rhythms to support sleep. How long melatonin lasts in your system depends on many factors, ...

The nonsteroidal anti-inflammatory drug (NSAID) flunixin meglumine has been approved by the FDA for fever associated with ...

Biocon’s ustekinumab biosimilar matched reference ustekinumab in efficacy and safety, while an adalimumab biosimilar proved ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.